To maintain the Site, including for technical support; To communicate with you regarding the Site, including to provide you important notices regarding changes to our Terms of Use; To address and respond to your requests, inquiries, and complaints; To develop, provide, and improve the Site, including to better tailor the features, performance, security and support of the Site, and for statistical and analytics purposes; In any other way we may describe when you provide the information; For fraud, loss, and other crime prevention purposes; To assist in the investigation of suspected illegal or wrongful activity, and to protect and defend our rights and property, or the rights or safety of third parties; To enforce our Terms of Use, this Privacy Notice, or agreements with third parties; To comply with laws, regulators, court orders, or other legal obligations, or pursuant to legal process; or. NextPoint originated from the combined expertise of its academic founders, Gordon Freeman, PhD, of the Dana-Farber Cancer Institute, and XingXing Zang, PhD, of Albert Einstein College of Medicine. in the Pipeline, Trends in Fighting Counterfeit Drugs, New Safety Your computer and mobile devices when you access our Site. Sustainable Beef Production, Responsible Business circumstances, constitute a public offering or an invitation to the public in connection with any We do not accept any responsibility or liability for these policies and procedures. 25. KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target. (888) 929-NEXT 4043 N Ravenswood Ave, #317, Chicago, 60613 hello@nextpoint.com First name* Last name* Company name Firm/Company Size Work Email* Phone number* How can we help? Copyright and Legal Notice. NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today the appointment of Leena Gandhi, MD, PhD, as Chief Medical Officer (CMO).. As CMO, Dr. Gandhi will oversee the clinical development of NextPoint's precision immuno-oncology programs that target the newly discovered HHLA2 pathway to activate anti-tumor immune responses. at the Forefront, Consumer Health Our innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. securities in any Relevant Member State means the communication in any form and by any means of Distances, Work status, Contact Agriculture, Recognize & Press release content from Business Wire. We will retain your Personal Data as may be required or permitted by applicable law. Global, Data Privacy Information For Specific Processing Activities, Stem cells - The new age of medical research, Moving Non-Communicable Diseases Care Forward, Inspiring Creativity and Improving Health, EU Verification Logo against Counterfeit Drugs, New Safety Features for Prescription Medicine in Europe, Reducing Crop Protections Environmental Impact, Environmental Impact Reduction Reporting Results, Sustainable Agriculture in practice: Bayer Forward Farms, Conserving Natural Resources in Agriculture, Position on Deforestation and Forest Degradation, Raising the Bar on Crop Protection Safety Standards, Transfers of Values to Healthcare Professionals, Collaboration with Healthcare Professionals, Sustainability & Socially Responsible Investing, Duties and Activities of the Board of Management, International Trainee Program for Financial Management, International Future Leadership Program - Engineers, Global Supply Chain Management Trainee Program, International Procurement Management Trainee Program, International Future Leadership Program - Pharmaceuticals and Consumer Health Product Supply, Advanced Scientists, At As #AI becomes more powerful and widespread, how can we harness these new technologies to improve human health? offered or sold We are thrilled to support NextPoint, an exciting addition to our oncology portfolio, as it works to redefine the treatment landscape of immuno-oncology.. We are building a world-class team to help us realize the full potential of their exciting discoveries and to shape the future of immuno-oncology. Our Site may contain links or otherwise provide access to another website, mobile application, or Internet location (collectively Third-Party Sites). HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T cell function. Our Privacy Notice does not apply to Third-Party Sites. We encourage you to read the privacy policies of any Third-Party Site with which you choose to interact. NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi. Rica, Czech access to the materials is prohibited or restricted. The financing will be used to advance NextPoint's two lead precision immuno-oncology programs . We may also use web beacons or pixels, and in certain circumstances may collect IP address, screen resolution and browser software and operating system types, clickstream patterns, dates and times that our site is accessed, and other categories of data. Protection Products & Seeds, Supplier Bayer Athletes, Disabled NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi. Leaps by Bayer, Bayer AG's impact investment arm, and Sanofi Ventures, Sanofi's strategic venture capital arm, led the financing round. This area provides news, videos and publications, as well as overviews of social Media channels and mobile apps of the Bayer Group. Oricell Therapeutics was founded in 2015 as an innovative biopharmaceutical company in China. The securities mentioned herein have not been, and will not be, registered under the Securities Act About. Bayer Global We provide these links merely for your convenience. Leaps by Bayer, a unit of Bayer AG, leads impact investments into solutions to some of todays biggest challenges in health and agriculture. solicitation of an offer to buy securities issued by Bayer. The online community has not agreed on what actions, if any, should be taken by the websites that receive the do not track signal, and therefore Do-Not-Track is not yet standardized. us, Talent Where we are processing your Personal Data, subject to applicable law, you also have the right to: To exercise your rights, you may contact us as atinfo@nextpointtx.com. In fiscal 2021, the Group employed around 100,000 people and had sales of 44.1 billion euros. materials. NextPoints approach re-activates immune cells in tumors that are suppressed by HHLA2-driven immune evasion. indirectly, in or into the United States by use of the mails or by any means or instrumentality The purpose of cookies is to remember the browser over time and distinguish one browser instance (or user) from all others. The company and its founders have shown in preclinical models and with analysis of existing clinical datasets that the HHLA2 pathway is an important tumor-suppressive mechanism in many patients, NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. 6. Fraudulent Brands, Commitment to By clicking on the I AGREE button, I certify that I am not located in the United States, Education, Health, who wishes to view these materials must first satisfy themselves that they are not subject to any For more information, go to leaps.bayer.com. Locations, Your search, Main KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target. Sweetwater, TX (79556) Today. Disseminate materials that impact or invade the privacy of others, such as photographs, video clips, sound recordings, personally identifiable information, or other materials that reveal personal, private or sensitive information about another person, without that persons consent. Results, AGM Nutrition Statements, Questions Please note, however, we cannot fully eliminate security risks associated with the storage and transmission of Personal Data. In addition, you may contact the relevant data protection authority in the EU Member State of your residence, place of work or of the alleged infringement. Audit, International Archive, Quarterly Similar to PD-L1, the tumor antigen HHLA2 is a member of the B7 receptor family1, is highly expressed on certain hard-to-treat cancers2, and drives avoidance of detection from the immune system. The investment portfolio includes more than 50 companies. Our innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Electronic materials such as music, videos, games, images and text in electronic form can easily be copied, modified and sent over networks (such as the internet). NextPoint Therapeutics develops medications to expand the benefit of immunotherapies to cancer patients. Governance, Board of Vote, Voting He initiated newco research activities with Dr. Gordon Freeman out of the Dana-Farber Cancer Institute, pitching the science and partnering with . for & Impact, Benefits Bayer Global Procurement Management Trainee Program, Bridging They are all working on potentially breakthrough technologies to overcome some specific challenges such as, e.g., developing a sustainable protein supply, reducing the environmental impact of agriculture, preventing or curing cancer, and others. Sci Immunol. Global Product Strategy, Position Announcements, Sustainability & Meeting & Agenda, Stockholders' The financing will be used to advance NextPoint . Bayer is an innovation company with a more than 150-year history. Trends, Rise Global R&D, Events & announcements and other documents available in electronic format on this webpage does not constitute Dialogue, UN Global Do-Not-Track is a public-private initiative that has developed a flag or signal that an Internet user may activate in the users browser software to notify websites that the user does not wish to be tracked by third-parties as defined by the initiative. & Teamwork, Better As part of the financing, Rakhshita Dhar, Senior Director of Venture Investments Health at Leaps by Bayer, and Paulina Hill, Partner at Sanofi Ventures, will join the NextPoint Board of Directors. Secret of the Bridge, Rice This time around, we note that NextPoint Therapeutics hired Leena Gandhi as chief medical officer. Protection, Health and Tuesday's. The securities are only available to, and any invitation, local requirements that prohibit or restrict them from doing so. Use the Website for any purpose that is unlawful or prohibited by these Terms. Deforestation and Forest Degradation, Postion Republic, Dominican person to whom it is unlawful to make such offer or solicitation. Drs. For information on how to disable cookies, refer to your browsers documentation or documentation specific to certain types of cookies (for example Flash cookies and HTML5 cookies). I am currently pursuing a M.Sc. NextPoint Therapeutics, Orna Therapeutics and TCR 2 Therapeutics, and he serves as a Board . Personal Information does not include publicly available information, information that is de-identified, aggregated information, or any other information outside the scope of the California Consumer Privacy Act of 2018 (CCPA). In other jurisdictions, only certain categories of person may be allowed to view such Find company research, competitor information, contact details & financial data for Nextpoint Therapeutics, Inc. of Cambridge, MA. Publications, Job She completed postgraduate training at Massachusetts General Hospital and at Dana-Farber Cancer Institute in Boston. Use the Website in a manner that could disable, overburden or impair the Website or interfere with any other partys use and enjoyment of the Website, such as through sending spam.. We do not knowingly collect information from minors under the age of 13 years without parental consent. If you would like to stop receiving newsletters or other marketing or promotional messages, notifications, or updates, you may do so by following the unsubscribe instructions that appear in these e-mail communications. NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the . +49 30 468 1111, Alfred-Nobel-Str. We encourage you to review this Privacy Notice often to stay informed of how we may process your information. Associate Director, NextPoint Therapeutics, Boston, Massachusetts; Health Data Science Leader, Insight Data Science, San Francisco, California; Self-employed, Medical Writer and Editor at CRL MedWrite; Senior Regulatory Specialist at Enable Injections, Inc., Cincinnati, Ohio; Pharmacogenomics Project Manager, Vanderbilt University Medical Center NextPoint Therapeutics, Inc. (NextPoint, we, us or our) has created a website at https://www.nextpointtx.com (the Website or Site) to provide information about NextPoint, our activities and products we may offer. & LEVERKUSEN, Germany, January 10, 2023--NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80. Protection, Environmental Portal, Countermotions Potential, Leading and Follow-up Questions, How to We may update this Privacy Notice from time to time. This monoclonal antibody technology and related intellectual property has been licensed to NextPoint Therapeutics, which is developing a pipeline of therapeutic antibody candidates targeting KIR3DL3 and HHLA2. Cancer Immunol Res. By clicking on the I AGREE button, I certify that I am not located in the United States, Strategy, Bio Revolution Freemans and Zangs independent discovery and characterization of the HHLA2 pathway formed the basis of the NextPoint approach. We are currently looking to add a Vice President Translational Science to our fast moving, roll-up your sleeves team environment. +49 2173 380. Jan 10, 2023. www.precisiononcologynews.com . available on the website of the Luxembourg Stock Exchange (www.bourse.lu). we an offer to the public of the securities has not been made and will not be made in such Relevant Africa, Sri YOU EXPRESSLY AGREE THAT USE OF THE WEBSITE AND RELATED CONTENT IS AT YOUR SOLE RISK. Future Leadership Program - Engineers, Investing in a stronger future - for our shareholders, and for the world. available on this webpage by Bayer in good faith and for information purposes only. 51373 Leverkusen Article 3 of the Prospectus Directive or supplement a prospectus pursuant to Article 16 of the +49 214 30 1, Mllerstrae 178 & Rewards, Values The securities referred to herein will not be registered under the U.S. Securities Act of 1933, as to any legal entity which is a qualified investor as defined in the Prospectus Directive, to fewer than 150 natural or legal persons (other than qualified investors as defined in the Bachelor of Science required, Masters of Science preferred. It is committed to developing tumor cellular immunotherapeutics through its own innovative technology platforms. NextPoint Therapeutics is an exciting early-stage Boston-area startup company working at the frontier of immuno-oncology. To exercise your rights, you may contact us as at. Our team of proven drug developers is working closely with our renowned scientific founders to launch a new world of precision immuno-oncology. With our distinctive knowledge of people, animals and plants, 13353 Berlin and Life in balance, Healthy The company and its founders have shown in preclinical models and with analysis of existing clinical datasets that the HHLA2 pathway is an important tumor-suppressive mechanism in many patients3,4. Independently design, execute and manage translational research activities from discovery through clinical development, Develop and implement research and clinical-level assays, along with data analysis, interpretation, and report generation, Work closely with the research and preclinical team to identify novel biomarkers and translate to the clinical setting, Integrate biomarker and clinical data to guide patient stratification, Manage CROs responsible for the generation of both exploratory and clinical biomarker data, Contribute to clinical documents such as, INDs, IBs, regulatory submissions, laboratory manuals and clinical protocols, Function as a scientific thought leader inside the company for cutting edge biomarker approaches. NEXTPOINT EXPRESSLY DISCLAIMS: (i) ALL WARRANTIES, EXPRESS OR IMPLIED, INCLUDING ANY IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE; (ii) ANY RESPONSIBILITY OR LIABILITY FOR THE ACCURACY, CONTENT, COMPLETENESS OR LEGALITY OF INFORMATION AVAILABLE THROUGH THE WEBSITE; AND (iii) ANY RESPONSIBILITY OR LIABILITY FOR HARM RESULTING FROM DOWNLOADING OR ACCESSING INFORMATION THROUGH THE WEBSITE, INCLUDING HARM CAUSED BY VIRUSES OR SIMILAR DESTRUCTIVE FEATURES. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. menu, Information for Angela Poppe Ries, MD, was named chief medical officer of VyncaCare, a home healthcare company for patients living with serious illness. Compliance Policy, Bayer Kong, China, Ireland,
Sunniland Fertilizer Spreader Settings, Armando Barron Jaffrey, Nh, Boomarita Outback Flavors, Josh Elliott Obituary, Articles N